Orthopaedic doctor says ‘adding probiotics to your diet can help control joint arthritis, joint pain': Here's how
Also Read | Gastroenterologist shares top 10 spices and herbs that your gut loves: From haldi to cinnamon and ajwain
In a post shared on June 4, Dr Tushar Gupta, MCh joint replacement and arthroscopy (AIIMS), MBBS, MS Orthopaedics, talked about the importance of consuming probiotics on joint health. Sharing the video, the orthopaedic doctor wrote, 'Probiotics treat arthritis.'
How does eating probiotics help with joint arthritis?
The orthopaedic expert stated in the Instagram video that adding probiotics to your diet can help you control your joint arthritis. He explained, 'Having probiotics and an anti-inflammatory diet can control your gut-joint axis and prevent or control the rate of progression of arthritis. These dietary substances can modulate gut bacteria, leading to a healthier bloodstream and decreased inflammation throughout your body. They can also help control your joint-related pain.'
Which probiotics are effective?
According to the Cleveland Clinic, for a probiotic to have any benefit to your health, it must:
Be of a variety that has proven benefits for your body.
Be in a form that's safe to consume or apply to your body.
Contain viable microbes that have survived the commercial process.
Be able to survive the journey through your digestive tract (if it's an oral probiotic).
Surprising probiotic foods found in Indian kitchens
In an interview with HT Lifestyle, AIIMS and ICMR-trainer Pariksha Rao, Director - nutrition and medical affairs, The Good Bug, shared a list of probiotic-rich foods found in our Indian kitchens. Here are a few examples:
Paneer
Idlis and dosas
Chaas (Buttermilk)
Pickles (Achaar)
Kanji
Dhokla
Gundruk and panta bhat
Sol kadhi
Green peas and beetroot
Apples and whole wheat bread: Rich in both probiotics and dietary fibre.
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
7 ways to reduce heartburn naturally: Chewing sugar‑free gum after meals, sleeping on left side, and more
Sick of that annoying burning in your chest after a great meal or worse, being woken up by acid creeping up your throat? You're not alone. The good news? You don't need to pop pills every time. According to Dr Saurabh Sethi, a Harvard and AIIMS-trained gastroenterologist in his instagram post, small changes like chewing sugar-free gum after meals and sleeping on your left side can make a huge difference. In an Instagram post, he shared these simple yet science-backed fixes as his top tips for reducing acid reflux and now clinical studies back him up. So if you're ready to kick heartburn to the curb naturally, here are seven proven ways to do exactly that. 7 ways you can reduce your heartburn naturally Chewing sugar‑free gum after meals reduces acid levels A small clinical trial conducted in London in 2005 followed 31 participants to see how chewing gum affects acid levels in the oesophagus after eating. The researchers measured how long the participants' oesophageal pH stayed below 4, a level considered highly acidic and linked to heartburn. Normally, after a meal, the acid level stayed low for about 5.7% of the time. But when participants chewed sugar-free gum for 30 minutes after eating, that acid exposure time dropped significantly to just 3.6%. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo That's a meaningful difference. So, how does chewing gum help? It's all about saliva. Chewing gum increases the amount of saliva your mouth produces, and all that extra swallowing helps push acid back down into the stomach, where it belongs. This simple habit helps clear acid more quickly and may ease or prevent reflux symptoms naturally. Sleeping on your left side reduces nighttime heartburn A study conducted at Amsterdam UMC with 58 people suffering from GERD (acid reflux) found something surprisingly simple that can make a big difference, sleeping on your left side. Compared to lying on the right side or flat on your back, left-side sleeping significantly reduced nighttime acid exposure. Why? Because gravity plays a big role. When you lie on your left, your stomach is positioned lower than your oesophagus, which helps keep stomach acid where it belongs. This position makes it harder for acid to flow upward and cause those painful reflux episodes while you sleep. Elevating the head while sleeping helps prevent reflux Several clinical trials and research reviews have shown that raising the head of your bed by 6 to 8 inches can significantly reduce acid reflux symptoms during the night. When you sleep flat, stomach acid can more easily creep up into the oesophagus, especially if your lower oesophageal sphincter is weak. But by elevating your upper body, gravity helps keep acid in your stomach where it belongs. This simple change, using risers under your bed or a wedge pillow, has been proven to lower oesophageal acid exposure and improve sleep quality for people with GERD. Eating smaller meals reduces pressure on the LES Large meals stretch the stomach and relax the lower oesophageal sphincter (LES), making reflux more likely. Controlled studies show that smaller, frequent meals ease pressure and reduce acid episodes, especially when combined with upright posture. Avoiding late‑night meals gives the stomach time to empty Eating within 2–3 hours of bedtime increases reflux risk. Research shows that allowing digestion time before lying down significantly reduces nocturnal symptoms and improves sleep quality in GERD patients. Limiting trigger foods cuts reflux at the source Foods like coffee, chocolate, mint, citrus, alcohol, and fried snacks can relax the LES or spike acid production. Controlled dietary interventions demonstrate improved reflux symptoms within weeks of removing these triggers from daily meals. Staying upright after eating aids digestion One of the simplest ways to beat heartburn? Just stay upright after you eat. Whether you're taking a short walk or just relaxing in a chair, keeping your body vertical for 20 to 30 minutes gives gravity a chance to help your food move down and settle properly. This small habit can make a big difference. In fact, a 2020 study found that three out of four people with acid reflux felt better just by doing this one thing. So next time you finish a meal, resist the urge to lie down, it could save you from that all-too-familiar burning sensation. You don't always need to reach for antacids or prescriptions to keep heartburn at bay. In fact, some of the most effective acid reflux remedies are simple lifestyle tweaks backed by science. Chewing sugar-free gum after meals can help neutralise acid faster, while sleeping on your left side keeps stomach contents where they belong thanks to gravity. Even small changes, like avoiding late-night meals, sitting upright after eating, and elevating the head of your bed can make a big difference. These natural solutions may sound basic, but when used consistently, they work. Try a few and see how your body responds, your digestive system (and sleep schedule) will thank you. Also read| Sleepwalking: Causes, symptoms and common triggers explained Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Scroll.in
2 hours ago
- Scroll.in
As young Indians turn to AI ‘therapists', how confidential is their data?
This is the second of a two-part series. Read the first here. Imagine a stranger getting hold of a mental health therapist's private notes – and then selling that information to deliver tailored advertisements to their clients. That's practically what many mental healthcare apps might be doing. Young Indians are increasingly turning to apps and artificial intelligence-driven tools to address their mental health challenges – but have limited awareness about how these digital tools process user data. In January, the Centre for Internet and Society published a study based on 45 mental health apps – 28 from India and 17 from abroad – and found that 80% gathered user health data that they used for advertising and shared with third-party service providers. An overwhelming number of these apps, 87%, shared the data with law enforcement and regulatory bodies. The first article in this series had reported that some of these apps are especially popular with young Indian users, who rely on them for quick and easy access to therapy and mental healthcare support. Users had also told Scroll that they turned to AI-driven technology, such as ChatGPT, to discuss their feelings and get advice, however limited this may be compared to interacting with a human therapist. But they were not especially worried about data misuse. Keshav*, 21, reflected a common sentiment among those Scroll interviewed: 'Who cares? My personal data is already out there.' The functioning of Large Language Models, such as ChatGPT, is already under scrutiny. LLMs are 'trained' on vast amounts of data, either from the internet or provided by its trainers, to simulate human learning, problem solving and decision making. Sam Altman, CEO of OpenAI that built ChatGPT, said on a podcast in July that though users talk about personal matters with the chatbot, there are no legal safeguards protecting that information. 'People use it – young people, especially, use it – as a therapist, a life coach; having these relationship problems and [asking] what should I do?' he asked. 'And right now, if you talk to a therapist or a lawyer or a doctor about those problems, there's legal privilege for it. There's doctor-patient confidentiality, there's legal confidentiality, whatever. And we haven't figured that out yet for when you talk to ChatGPT.' Play He added: 'So if you go talk to ChatGPT about your most sensitive stuff and then there's like a lawsuit or whatever, we could be required to produce that, and I think that's very screwed up.' Therapists and experts said the ease of access of AI-driven mental health tools should not sideline privacy concerns. Clinical psychologist Rhea Thimaiah, who works at Kaha Mind, a collective that provides mental health services, emphasised that confidentiality is an essential part of the process of therapy. 'The therapeutic relationship is built on trust and any compromise in data security can very possibly impact a client's sense of safety and willingness to engage,' she said. 'Clients have a right to know how their information is being stored, who has access, and what protections are in place.' This is more than mere data – it is someone's memories, trauma and identity, Thimaiah said. 'If we're going to bring AI into this space, then privacy shouldn't be optional, it should be fundamental.' Srishti Srivastava, founder of AI-driven mental health app Infiheal, said that her firm collects user data to train its AI bot, but users can access the app even without signing up and also ask for their data to be deleted. Dhruv Garg, a tech policy lawyer at Indian Governance and Policy Project, said the risk lies not just in apps collecting data but in the potential downstream uses of that information. 'Even if it's not happening now, an AI platform in the future could start using your data to serve targeted ads or generate insights – commercial, political, or otherwise – based on your past queries,' said Garg. 'Current privacy protections, though adequate for now, may not be equipped to deal with each new future scenario.' India's data protection law For now, personal data processed by chatbots is governed by the Information Technology Act framework and Sensitive Personal Data Rules, 2011. Section 5 of the sensitive data rules says that companies must obtain consent in writing before collecting or using sensitive information. According to the rules, information relating to health and mental health conditions are considered sensitive data. There are also specialised sectoral data protection rules that apply to regulated entities like hospitals. The Digital Personal Data Protection Act, passed by Parliament in 2023, is expected to be notified soon. But it exempts publicly available personal data from its ambit if this information has voluntarily been disclosed by an individual. Given the black market of data intermediaries that publish large volumes of personal information, it is difficult to tell what personal data in the public domain has been made available 'voluntarily'. The new data protection act does not have different regulatory standards for specific categories of personal data – financial, professional, or health-related, Garg said. This means that health data collected by AI tools in India will not be treated with special sensitivity under this framework. 'For instance, if you search for symptoms on Google or visit WebMD, Google isn't held to a higher standard of liability just because the content relates to health,' said Garg. WebMD provides health and medical information. It might be different for AI tools explicitly designed for mental healthcare – unlike general-purpose models like ChatGPT. These, according to Garg, 'could be made subject to more specific sectoral regulations in the future'. However, the very logic on which AI chatbots function – where it responds based on user data and inputs – could itself be a privacy risk. Nidhi Singh, a senior research analyst and programme manager at Carnegie India, an American think tank, said she has concerns about how tools like ChatGPT customise responses and remember user history – even though users may appreciate those functions. Singh said India's new data protection is quite clear that any data made publicly available by putting it on the internet is no longer considered personal data. 'It is unclear how this will apply to your conversations with ChatGPT,' she said. Without specific legal protections, there's no telling how an AI-driven tool will use the data it has gathered. According to Singh, without a specific rule designating conversations with generative AI as an exception, it is likely that a user's interactions with these AI systems won't be treated as personal data and consequently will not fall under the purview of the act. Who takes legal responsibility? Technology firms have tried hard to evade legal liability for harm. In Florida, a lawsuit by a mother has alleged that her 14-year-old son died by suicide after becoming deeply entangled in an 'emotionally and sexually abusive relationship' with a chatbot. In case of misdiagnosis or harmful advice from an AI tool, legal responsibility is likely to be analysed in court, said Garg. 'The developers may argue that the model is general-purpose, trained on large datasets, and not supervised by a human in real-time,' said Garg. 'Some parallels may be drawn with search engines – if someone acts on bad advice from search results, the responsibility doesn't fall on the search engine, but on the user.' Highlighting the urgent need for a conversation on sector-specific liability frameworks, Garg said that for now, the legal liability of AI developers will have to be assessed on a case-to-case basis. 'Courts may examine whether proper disclaimers and user agreements were in place,' he said. In another case, Air Canada was ordered to pay compensation to a customer who was misled by its chatbot regarding bereavement fares. The airline had argued that the chatbot was a ' separate legal entity ' and therefore responsible for its own actions. Singh of Carnegie India said that transparency is important and that user consent should be meaningful. 'You don't need to explain the model's source code, but you do need to explain its limitations and what it aims to do,' she said. 'That way, people can genuinely understand it, even if they don't grasp every technical step.' AI, meanwhile, is here for the long haul. Until India can expand its capacity to offer mental health services to everyone, Singh said AI will inevitably fill that void. 'The use of AI will only increase as Indic language LLMs are being built, further expanding its potential to address the mental health therapy gap,' she said.
The Hindu
3 hours ago
- The Hindu
Simpler tests could slash biosimilar costs, widen patient access
Most of the drugs that we consume are called 'small molecule drugs'. Their chemical structure is reasonably simple. Disprin, for instance, has a molecular weight of around 180 daltons. There is another breed of drugs that are very large, complex molecules. For instance, the molecular weight of insulin is around 5,800 daltons and that of the monoclonal antibody remicade, about 150,000 daltons. (One dalton is equal to one-12th the mass of a carbon-12 atom.) Small molecule drugs also tend to have fixed structures that do not change for the duration of their use. In contrast, the complex molecules, which we call biologics, are produced in biological systems and therefore during their production slight variations in the structure may arise. However, these variations may have no impact on the stability of the molecule, its efficacy or its side effects. When a company produces a small molecule drug for the first time, it seeks patent protection for that drug. That is, no competitor may make that drug for several years. It is only when the drug goes 'off patent' that competitors may make it. In the absence of competition, the originator company can price the drug very high. Once there is competition, the competitor companies produce generics, which are copies of the original drug. They don't undertake the research and development to make the drug and they may not spend as much on marketing and sales, so the costs of generics are also much lower. Most of the drugs that you and I take are generics and are priced very cheaply compared to the originator drug. A good example is Sovaldi, a drug used to treat hepatitis C: it originally cost $84,000 for a 12-week course in the US but that dropped to $1,000 once Indian generic firms started making it. Largely it is generic drugs that keep us in India alive and well. Since biologics made by a generic firm will be produced by different biological systems, they may not be identical to those made by the originator company. Thus they are called biosimilars, not generics. For many years, a debate has raged over how much proof is required for a manufacturer to prove that a given biosimilar will work as well as the original biologic drug. Therefore, whereas much simpler testing was required to show that a generic small molecule was working like the originator molecule, there are more elaborate and expensive tests for biosimilars. Major drug regulators such as those of the US, the UK, and in Europe have been working to determine how they can simplify the requirements for approving a biosimilar, in view of the availability of modern analytical techniques. For example, the UK has removed animal trials and the US has planned to replace them with more human-relevant methods (like using organoids). In India, this requirement has not yet been updated although there is a proposal to waive animal studies on a case-by-case basis. Some have also argued that India should follow the practices of the UK and the US. The same holds for the more expensive clinical trials, which in the UK are currently required only in certain cases. Biosimilars need to be made less expensively while ensuring efficacy and minimal adverse effects. The larger the number of affordable biosimilars, the more options we will have for our patients. Gayatri Saberwal is a consultant at the Tata Institute for Genetics and Society.
